Home Tags Amplexd Therapeutics

Amplexd Therapeutics

Amplexd Therapeutics, Inc. (“Amplexd” or the “Company”), a clinical stage patient-scientist-led biotech company specializing in accessible treatments for human papillomavirus (HPV)-induced Cervical Intraepithelial Neoplasia (CIN), is pleased to announce major updates in 2024 toward the finalization of product development ahead of Phase 1/2 clinical trials for its non-invasive treatments of CIN, the precursor to cervical cancer. The Company secures USD2million in funding for this initiative from an Asia-based life sciences focused family office.

[Funding News] MD-based Amplexd Therapeutics Secures USD2Million in Funding

Startuprise io -
© Copyright startuprise 2024 All Rights Reserved.
Exit mobile version